278 related articles for article (PubMed ID: 23343715)
21. MiR-137 inhibits proliferation and angiogenesis of human glioblastoma cells by targeting EZH2.
Sun J; Zheng G; Gu Z; Guo Z
J Neurooncol; 2015 May; 122(3):481-9. PubMed ID: 25939439
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-451 functions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14 (RAB14).
Wang R; Wang ZX; Yang JS; Pan X; De W; Chen LB
Oncogene; 2011 Jun; 30(23):2644-58. PubMed ID: 21358675
[TBL] [Abstract][Full Text] [Related]
23. The Long Non-Coding RNA XIST Controls Non-Small Cell Lung Cancer Proliferation and Invasion by Modulating miR-186-5p.
Wang H; Shen Q; Zhang X; Yang C; Cui S; Sun Y; Wang L; Fan X; Xu S
Cell Physiol Biochem; 2017; 41(6):2221-2229. PubMed ID: 28448993
[TBL] [Abstract][Full Text] [Related]
24. Circular RNA circ-PRMT5 facilitates non-small cell lung cancer proliferation through upregulating EZH2 via sponging miR-377/382/498.
Wang Y; Li Y; He H; Wang F
Gene; 2019 Dec; 720():144099. PubMed ID: 31479715
[TBL] [Abstract][Full Text] [Related]
25. Carcinogenesis of intraductal papillary mucinous neoplasm of the pancreas: loss of microRNA-101 promotes overexpression of histone methyltransferase EZH2.
Nakahara O; Takamori H; Iwatsuki M; Baba Y; Sakamoto Y; Tanaka H; Chikamoto A; Horino K; Beppu T; Kanemitsu K; Honda Y; Iyama K; Baba H
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S565-71. PubMed ID: 21932133
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-370 inhibits the progression of non-small cell lung cancer by downregulating oncogene TRAF4.
Chen T; Gao F; Feng S; Yang T; Chen M
Oncol Rep; 2015 Jul; 34(1):461-8. PubMed ID: 25976502
[TBL] [Abstract][Full Text] [Related]
27. The candidate oncogene (MCRS1) promotes the growth of human lung cancer cells via the miR-155-Rb1 pathway.
Liu M; Zhou K; Huang Y; Cao Y
J Exp Clin Cancer Res; 2015 Oct; 34():121. PubMed ID: 26467212
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-1297 regulates hepatocellular carcinoma cell proliferation and apoptosis by targeting EZH2.
Liu F; He Y; Shu R; Wang S
Int J Clin Exp Pathol; 2015; 8(5):4972-80. PubMed ID: 26191190
[TBL] [Abstract][Full Text] [Related]
29. MiR-138 Acts as a Tumor Suppressor by Targeting EZH2 and Enhances Cisplatin-Induced Apoptosis in Osteosarcoma Cells.
Zhu Z; Tang J; Wang J; Duan G; Zhou L; Zhou X
PLoS One; 2016; 11(3):e0150026. PubMed ID: 27019355
[TBL] [Abstract][Full Text] [Related]
30. MiR-101 inhibits melanoma cell invasion and proliferation by targeting MITF and EZH2.
Luo C; Merz PR; Chen Y; Dickes E; Pscherer A; Schadendorf D; Eichmüller SB
Cancer Lett; 2013 Dec; 341(2):240-7. PubMed ID: 23962556
[TBL] [Abstract][Full Text] [Related]
31. MiR-340 impedes the progression of laryngeal squamous cell carcinoma by targeting EZH2.
Yu W; Zhang G; Lu B; Li J; Wu Z; Ma H; Wang H; Lian R
Gene; 2016 Feb; 577(2):193-201. PubMed ID: 26656176
[TBL] [Abstract][Full Text] [Related]
32. microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C.
Hu J; Cheng Y; Li Y; Jin Z; Pan Y; Liu G; Fu S; Zhang Y; Feng K; Feng Y
Eur J Cancer; 2014 Sep; 50(13):2336-50. PubMed ID: 25001183
[TBL] [Abstract][Full Text] [Related]
33. MiR-138 inhibits cell proliferation and reverses epithelial-mesenchymal transition in non-small cell lung cancer cells by targeting GIT1 and SEMA4C.
Li J; Wang Q; Wen R; Liang J; Zhong X; Yang W; Su D; Tang J
J Cell Mol Med; 2015 Dec; 19(12):2793-805. PubMed ID: 26283050
[TBL] [Abstract][Full Text] [Related]
34. EZH2-mediated epigenetic suppression of long noncoding RNA SPRY4-IT1 promotes NSCLC cell proliferation and metastasis by affecting the epithelial-mesenchymal transition.
Sun M; Liu XH; Lu KH; Nie FQ; Xia R; Kong R; Yang JS; Xu TP; Liu YW; Zou YF; Lu BB; Yin R; Zhang EB; Xu L; De W; Wang ZX
Cell Death Dis; 2014 Jun; 5(6):e1298. PubMed ID: 24967960
[TBL] [Abstract][Full Text] [Related]
35. Posttranscriptional silencing of the lncRNA MALAT1 by miR-217 inhibits the epithelial-mesenchymal transition via enhancer of zeste homolog 2 in the malignant transformation of HBE cells induced by cigarette smoke extract.
Lu L; Luo F; Liu Y; Liu X; Shi L; Lu X; Liu Q
Toxicol Appl Pharmacol; 2015 Dec; 289(2):276-85. PubMed ID: 26415832
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-144 suppresses tumorigenesis and tumor progression of astrocytoma by targeting EZH2.
Lin L; Zheng Y; Tu Y; Wang Z; Liu H; Lu X; Xu L; Yuan J
Hum Pathol; 2015 Jul; 46(7):971-80. PubMed ID: 25907866
[TBL] [Abstract][Full Text] [Related]
37. MiR-142-3p functions as a potential tumor suppressor directly targeting HMGB1 in non-small-cell lung carcinoma.
Xiao P; Liu WL
Int J Clin Exp Pathol; 2015; 8(9):10800-7. PubMed ID: 26617792
[TBL] [Abstract][Full Text] [Related]
38. MiR-32 functions as a tumor suppressor and directly targets EZH2 in human oral squamous cell carcinoma.
Zhang D; Ni Z; Xu X; Xiao J
Med Sci Monit; 2014 Dec; 20():2527-35. PubMed ID: 25472588
[TBL] [Abstract][Full Text] [Related]
39. Antitumor effects of pharmacological EZH2 inhibition on malignant peripheral nerve sheath tumor through the miR-30a and KPNB1 pathway.
Zhang P; Yang X; Ma X; Ingram DR; Lazar AJ; Torres KE; Pollock RE
Mol Cancer; 2015 Mar; 14():55. PubMed ID: 25890085
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic therapy with 3-deazaneplanocin A, an inhibitor of the histone methyltransferase EZH2, inhibits growth of non-small cell lung cancer cells.
Kikuchi J; Takashina T; Kinoshita I; Kikuchi E; Shimizu Y; Sakakibara-Konishi J; Oizumi S; Marquez VE; Nishimura M; Dosaka-Akita H
Lung Cancer; 2012 Nov; 78(2):138-43. PubMed ID: 22925699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
